Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancer. [electronic resource]
Producer: 20150625Description: 8750-64 p. digitalISSN:- 1949-2553
- Aged
- Aged, 80 and over
- Animals
- Antineoplastic Agents -- pharmacology
- Biomarkers, Tumor -- genetics
- Drug Resistance, Neoplasm -- genetics
- Female
- Gene Expression Profiling
- Gene Expression Regulation, Neoplastic
- Gene Regulatory Networks
- High-Throughput Nucleotide Sequencing
- Humans
- Immunohistochemistry
- Mice, SCID
- Middle Aged
- Neoplasm Transplantation
- Neoplastic Stem Cells -- drug effects
- Ovarian Neoplasms -- drug therapy
- Patient Selection
- Polymerase Chain Reaction
- Precision Medicine
- Predictive Value of Tests
- Time Factors
- Tumor Burden -- drug effects
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.